Biochemistry and medicinal chemistry of the dengue virus protease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Chemical Reviews

• Publication date

  2014-09-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/cr500233qPMID 25268322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.

  2014cited by this paper
• Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology.

  2014cited by this paper
• Small molecule inhibitor discovery for dengue virus protease using high-throughput screening.

  2014cited by this paper
• Dengue Viral Protease Interaction with NF-κB Inhibitor α/β Results in Endothelial Cell Apoptosis and Hemorrhage Development

  2014cited by this paper
• C-terminal residue optimization and fragment merging: discovery of a potent Peptide-hybrid inhibitor of dengue protease.

  2014cited by this paper
• The dengue virus NS2B–NS3 protease retains the closed conformation in the complex with BPTI

  2014cited by this paper
• Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?

  2014cited by this paper
• Chronic hepatitis C: future treatment

  2014cited by this paper
• Binding mode of the activity‐modulating C‐terminal segment of NS2B to NS3 in the dengue virus NS2B–NS3 protease

  2014cited by this paper
• An inhibition model of BPTI to unlinked dengue virus NS2B‐NS3 protease

  2014cited by this paper
• Fusion of Protegrin-1 and Plectasin to MAP30 Shows Significant Inhibition Activity against Dengue Virus Replication

  2014cited by this paper
• Lyso-myristoyl phosphatidylcholine micelles sustain the activity of Dengue non-structural (NS) protein 3 protease domain fused with the full-length NS2B.

  2013cited by this paper
• Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture.

  2013cited by this paper
• Rational Discovery of Dengue Type 2 Non‐Competitive Inhibitors

  2013cited by this paper
• Fluorimetric and HPLC-based dengue virus protease assays using a FRET substrate.

  2013cited by this paper
• NMR Analysis of a Novel Enzymatically Active Unlinked Dengue NS2B-NS3 Protease Complex*

  2013cited by this paper
• Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.

  2013cited by this paper
• A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication.

  2013cited by this paper
• Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMR.

  2013cited by this paper
• A Novel Dengue Virus Inhibitor, BP13944, Discovered by High-Throughput Screening with Dengue Virus Replicon Cells Selects for Resistance in the Viral NS2B/NS3 Protease

  2013cited by this paper
• Dengue viruses – an overview

  2013cited by this paper
• Antiviral Cationic Peptides as a Strategy for Innovation in Global Health Therapeutics for Dengue Virus: High Yield Production of the Biologically Active Recombinant Plectasin Peptide

  2013cited by this paper
• The global distribution and burden of dengue

  2013cited by this paper
• Design and evaluation of substrate-based octapeptide and non substrate-based tetrapeptide inhibitors of dengue virus NS2B-NS3 proteases.

  2013cited by this paper
• Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus.

  2013cited by this paper
• Inter- and Intra-Host Viral Diversity in a Large Seasonal DENV2 Outbreak

  2013cited by this paper
• Current progress in dengue vaccines

  2013cited by this paper
• Inhibitory effect of doxycycline against dengue virus replication in vitro

  2013cited by this paper
• Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B/NS3 proteases.

  2013cited by this paper
• In Vitro Evaluation of Novel Inhibitors against the NS2B-NS3 Protease of Dengue Fever Virus Type 4

  2013cited by this paper
• Ten years of dengue drug discovery: progress and prospects.

  2013cited by this paper
• Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro.

  2013cited by this paper
• Repeated introduction of Aedes albopictus into Germany, July to October 2012

  2013cited by this paper
• Allosteric inhibition of the NS2B-NS3 protease from dengue virus.

  2013cited by this paper
• The invasive mosquito species Aedes albopictus: current knowledge and future perspectives.

  2013cited by this paper
• Characterization of the 8-hydroxyquinoline scaffold for inhibitors of West Nile virus serine protease.

  2012cited by this paper
• Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives.

  2012cited by this paper
• Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry.

  2012cited by this paper
• Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity.

  2012cited by this paper
• Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1

  2012cited by this paper
• Backbone 1H, 13C and 15N resonance assignments of dengue virus NS2B–NS3p in complex with aprotinin

  2012cited by this paper
• Structural biology of dengue virus enzymes: towards rational design of therapeutics.

  2012cited by this paper
• Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.

  2012cited by this paper
• Protegrin-1 Inhibits Dengue NS2B-NS3 Serine Protease and Viral Replication in MK2 Cells

  2012cited by this paper
• Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors.

  2012cited by this paper
• Structural platform for the autolytic activity of an intact NS2B-NS3 protease complex from dengue virus.

  2012cited by this paper
• High-Resolution Analysis of Intrahost Genetic Diversity in Dengue Virus Serotype 1 Infection Identifies Mixed Infections

  2012cited by this paper
• Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold.

  2012cited by this paper
• Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping.

  2012cited by this paper
• Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease.

  2012cited by this paper
• Expression, purification, and initial structural characterization of nonstructural protein 2B, an integral membrane protein of Dengue-2 virus, in detergent micelles.

  2011cited by this paper
• Dengue protease activity: the structural integrity and interaction of NS2B with NS3 protease and its potential as a drug target.

  2011cited by this paper
• Structure-guided fragment-based in silico drug design of dengue protease inhibitors

  2011cited by this paper
• Ligand-Bound Structures of the Dengue Virus Protease Reveal the Active Conformation

  2011cited by this paper
• Small Molecule Pan-Dengue and West Nile Virus NS3 Protease Inhibitors

  2011cited by this paper
• Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.

  2011cited by this paper
• Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.

  2011cited by this paper
• Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts.

  2011cited by this paper
• The pathogenesis of dengue.

  2011cited by this paper
• Virtual Ligand Screening of the National Cancer Institute (NCI) Compound Library Leads to the Allosteric Inhibitory Scaffolds of the West Nile Virus NS3 Proteinase

  2011cited by this paper
• Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture.

  2011cited by this paper
• Anthracene-based inhibitors of dengue virus NS2B-NS3 protease.

  2011cited by this paper
• Novel Dengue Virus-Specific NS2B/NS3 Protease Inhibitor, BP2109, Discovered by a High-Throughput Screening Assay

  2010cited by this paper
• Dengue: a continuing global threat

  2010cited by this paper
• Flexibility between the Protease and Helicase Domains of the Dengue Virus NS3 Protein Conferred by the Linker Region and Its Functional Implications

  2010cited by this paper
• Structure-guided mutagenesis of active site residues in the dengue virus two-component protease NS2B-NS3

  2010cited by this paper
• Synthesis and disulfide bond connectivity-activity studies of a kalata B1-inspired cyclopeptide against dengue NS2B-NS3 protease.

  2010cited by this paper
• NMR Analysis of the Dynamic Exchange of the NS2B Cofactor between Open and Closed Conformations of the West Nile Virus NS2B-NS3 Protease

  2009cited by this paper
• Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.

  2009cited by this paper
• Optimization of Assay Conditions fo r Dengue Virus Protease: Effect of Various Polyols and Nonionic Detergents

  2009cited by this paper
• Serotype-Specific Structural Differences in the Protease-Cofactor Complexes of the Dengue Virus Family

  2009cited by this paper
• Covalent modifiers: an orthogonal approach to drug design.

  2009cited by this paper
• Structure-based discovery of dengue virus protease inhibitors.

  2009cited by this paper
• A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease.

  2009cited by this paper
• Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.

  2008cited by this paper
• Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases.

  2008cited by this paper
• Mechanism of NS2B-Mediated Activation of NS3pro in Dengue Virus: Molecular Dynamics Simulations and Bioassays

  2008cited by this paper
• Global spread and persistence of dengue.

  2008cited by this paper
• A comparative biochemical analysis of the NS2B(H)-NS3pro protease complex from four dengue virus serotypes.

  2008cited by this paper
• Identification and Biochemical Characterization of Small-Molecule Inhibitors of West Nile Virus Serine Protease by a High-Throughput Screen

  2008cited by this paper
• Switching the Substrate Specificity of the Two-Component NS2B-NS3 Flavivirus Proteinase by Structure-Based Mutagenesis

  2007cited by this paper
• Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.

  2007cited by this paper
• Cell-free transcription/translation from PCR-amplified DNA for high-throughput NMR studies.

  2007cited by this paper
• Functional Characterization of cis and trans Activity of the Flavivirus NS2B-NS3 Protease*

  2007cited by this paper
• Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold

  2007cited by this paper
• Characterization of the West Nile virus protease substrate specificity and inhibitors.

  2007cited by this paper
• Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.

  2007cited by this paper
• Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates.

  2007cited by this paper
• Progress for dengue virus diseases

  2007cited by this paper
• Combinatorial Computational Approaches to Identify Tetracycline Derivatives as Flavivirus Inhibitors

  2007cited by this paper
• Controlled peptide solvation in portion-mixing libraries of FRET peptides: improved specificity determination for Dengue 2 virus NS2B-NS3 protease and human cathepsin S.

  2007cited by this paper
• Crystal Structure of the NS3 Protease-Helicase from Dengue Virus

  2007cited by this paper
• Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.

  2006cited by this paper
• Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus

  2006cited by this paper
• Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.

  2006cited by this paper
• Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase.

  2006cited by this paper
• Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors.

  2006cited by this paper
• Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead.

  2006cited by this paper
• Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides

  2005cited by this paper
• Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells

  2005cited by this paper

• Super-resolution optical microscopy reveals accumulation of photoactivable dengue protein (Dendra2-NS2B) in the endoplasmic reticulum

  2025cites this paper
• CRISPR/Cas12a Protein Switch Powered Label-Free Electrochemical Biosensor for Sensitive Viral Protease Detection.

  2025cites this paper
• Inter-host diversity associated with age, sex, and menstrual cycle modulates clinical manifestations in DENV-2 patients

  2025cites this paper
• Neferine inhibits Zika virus replication by targeting viral protease.

  2025cites this paper
• Novel Thiazolidinedione Derivatives as Potential ZIKV Antiviral Inhibitors

  2025cites this paper
• Development of Lipopeptides as Orthoflavivirin Inhibitors with Low Micromolar Broad-Spectrum Antiorthoflaviviral Activity

  2025cites this paper
• De Novo Discovery of Bicyclic Competitive Inhibitors of Zika Virus Protease from Peptide–Bismuth Phage Display Screening

  2025cites this paper
• Dynamic claw of dengue protease unveils druggability potential with high affinity allosteric inhibitors

  2025cites this paper
• Identification of novel thiazole derivatives as flaviviral protease inhibitors effective against Dengue (DENV2) and Japanese encephalitis viruses

  2025cites this paper
• 4(3H)-Quinazolinone: A Natural Scaffold for Drug and Agrochemical Discovery

  2025cites this paper
• Characterisation of ten NS2B-NS3 proteases: Paving the way for pan-flavivirus drugs.

  2024cites this paper
• Yeast-Based Screening of Anti-Viral Molecules

  2024cites this paper
• Recent Advances on Targeting Proteases for Antiviral Development

  2024cites this paper
• Carbazole to indolazepinone scaffold morphing leads to potent cell-active dengue antivirals.

  2024cites this paper
• Peptide-Drug Conjugates: An Emerging Direction for the Next Generation of Peptide Therapeutics.

  2024cites this paper
• A Non-Active-Site Inhibitor with Selectivity for Zika Virus NS2B-NS3 Protease.

  2024cites this paper
• Ligand-Based Design of Selective Peptidomimetic uPA and TMPRSS2 Inhibitors with Arg Bioisosteres

  2024cites this paper
• NS2B-D55E and NS2B-E65D Variations Are Responsible for Differences in NS2B-NS3 Protease Activities Between Japanese Encephalitis Virus Genotype I and III in Fluorogenic Peptide Model

  2024cites this paper
• Indole Derivatives as Promising Anti‐Dengue Agents: A Review of Recent Advances

  2024cites this paper
• Shifting paradigms: The promise of allosteric inhibitors against dengue virus protease.

  2024cites this paper
• Novel Antiviral Phytochemicals Against Dengue Virus 2 NS2B‐NS3 Protease: An In Silico Drug Development Approach

  2024cites this paper
• Proteases: Role in Various Human Diseases.

  2024cites this paper
• Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition

  2024cites this paper
• Recent advances in the study of zika virus structure, drug targets, and inhibitors

  2024cites this paper
• Antiviral Drug Discovery with an Optimized Biochemical Dengue Protease Assay: Improved Predictive Power for Antiviral Efficacy

  2024cites this paper
• 3D-QSAR and molecular docking studies of peptide-hybrids as dengue virus NS2B/NS3 protease inhibitors.

  2024cites this paper
• Repurposing of investigational cancer drugs: Early phase discovery of dengue virus NS2B/NS3 protease inhibitors

  2023cites this paper
• Targeting the proteases of arboviruses with cyclic and bicyclic peptides

  2023cites this paper
• The Anti-inflammatory Drug Leflunomide Inhibits NS2B3 Cluster Formation During Dengue Viral Infection as Revealed by Single Molecule Imaging

  2023cites this paper
• Proteases immobilized on nanomaterials for biocatalytic, environmental and biomedical applications: Advantages and drawbacks.

  2023cites this paper
• Exploring the viral protease inhibitor space driven by consensus scoring-based virtual screening

  2023cites this paper
• Combined NMR and molecular dynamics conformational filter identifies unambiguously dynamic ensembles of Dengue protease NS2B/NS3pro

  2023cites this paper
• Conformational Selection and Induced Fit: The Behavior of Two Homologous Proteases

  2023cites this paper
• Metal-Based Nanoparticles for the Diagnostics, Therapy, and Prevention of Viral Infections

  2023cites this paper
• Quinazolinone Compounds Have Potent Antiviral Activity against Zika and Dengue Virus.

  2023cites this paper
• The effects of allosteric and competitive inhibitors on ZIKV protease conformational dynamics explored through smFRET, nanoDSF, DSF, and 19F NMR.

  2023cites this paper
• The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022

  2023cites this paper
• Bioorthogonal Peptide Macrocyclization Using Oxime Ligation.

  2023cites this paper
• N-sulfonyl peptide-hybrids as a new class of dengue virus protease inhibitors.

  2023cites this paper
• Dengue virus NS4B protein as a target for developing antivirals

  2022cites this paper
• Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases

  2022influential citation
• Recent advances of carbon dots as new antimicrobial agents

  2022cites this paper
• An overview on small molecules acting as broad-spectrum agents for yellow fever infection

  2022cites this paper
• Cationic Geminoid Peptide Amphiphiles Inhibit DENV2 Protease, Furin, and Viral Replication

  2022cites this paper
• Computer-Aided Drug Design and ADMET of Novel Potent Dengue Virus NS-5 Inhibitors

  2022cites this paper
• Antiviral potential of nanoparticles for the treatment of Coronavirus infections

  2022cites this paper
• Identification and In Silico Binding Study of a Highly Potent DENV NS2B-NS3 Covalent Inhibitor.

  2022cites this paper
• Structures and Dynamics of Dengue Virus Nonstructural Membrane Proteins

  2022cites this paper
• Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study

  2022cites this paper
• A competition smFRET assay to study ligand‐induced conformational changes of the dengue virus protease

  2022cites this paper
• HQSAR, CoMFA, CoMSIA Docking Studies and Simulation MD on Quinazolines/Quinolines Derivatives for DENV Virus Inhibitory Activity

  2022cites this paper
• Functional Loop Dynamics and Characterization of the Inactive State of the NS2B-NS3 Dengue Protease due to Allosteric Inhibitor Binding

  2022cites this paper
• Facile Synthesis and In Vitro Activity of N-Substituted 1,2-Benzisothiazol-3(2H)-ones against Dengue Virus NS2BNS3 Protease

  2021cites this paper
• Beyond Basicity: Discovery of Nonbasic DENV-2 Protease Inhibitors with Potent Activity in Cell Culture.

  2021cites this paper
• The spectrum between substrates and inhibitors: Pinpointing the binding mode of dengue protease ligands with modulated basicity and hydrophobicity.

  2021cites this paper
• A short survey of dengue protease inhibitor development in the past 6 years (2015–2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases

  2021cites this paper
• Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.

  2021cites this paper
• Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review

  2021cites this paper
• Viral proteases: Structure, mechanism and inhibition

  2021cites this paper
• A Critical Observation on the Design and Development of Reported Peptide Inhibitors of DENV NS2B-NS3 Protease in the Last Two Decades.

  2021cites this paper
• Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease.

  2021cites this paper
• Structure and Dynamics of Zika Virus Protease and Its Insights into Inhibitor Design

  2021cites this paper
• Identification of potential ZIKV NS2B-NS3 protease inhibitors from Andrographis paniculata: An insilico approach

  2021cites this paper
• Targeting the protease of West Nile virus.

  2021cites this paper
• Montmorillonite with essential oils as antimicrobial agents, packaging, repellents, and insecticides: an overview.

  2021cites this paper
• Amidoxime prodrugs convert to potent cell-active multimodal inhibitors of the dengue virus protease.

  2021cites this paper
• Conformational Dynamics of the Dengue Virus Protease Revealed by Fluorescence Correlation and Single-Molecule FRET Studies.

  2021cites this paper
• 2-Cyanoisonicotinamide Conjugation: A Facile Approach to Generate Potent Peptide Inhibitors of the Zika Virus Protease.

  2021cites this paper
• SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B/NS3 proteases.

  2021cites this paper
• A biocompatible stapling reaction for in situ generation of constrained peptides

  2020cites this paper
• Identification and structural characterization of small molecule fragments targeting Zika virus NS2B-NS3 protease.

  2020cites this paper
• Inhibitors of the Zika virus protease NS2B-NS3.

  2020cites this paper
• Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate dengue from Zika and West Nile viruses.

  2020cites this paper
• Synthesis and evaluation of novel S-benzyl- and S-alkylphthalimide- oxadiazole -benzenesulfonamide hybrids as inhibitors of dengue virus protease.

  2020cites this paper
• New Cysteine Protease Inhibitors: Electrophilic (Het)arenes and Unexpected Prodrug Identification for the Trypanosoma Protease Rhodesain

  2020cites this paper
• An overview of functional nanoparticles as novel emerging antiviral therapeutic agents

  2020cites this paper
• Conformational selection in the flaviviral NS2B-NS3 protease.

  2020cites this paper
• Naphthoquinones as Covalent Reversible Inhibitors of Cysteine Proteases—Studies on Inhibition Mechanism and Kinetics

  2020cites this paper
• Probing contacts of inhibitor locked in transition states in the catalytic triad of DENV2 type serine protease and its mutants by 1H, 19F and 15 N NMR spectroscopy

  2020cites this paper
• Structure‐Based Macrocyclization of Substrate Analogue NS2B‐NS3 Protease Inhibitors of Zika, West Nile and Dengue viruses

  2020cites this paper
• A New Class of Dengue and West Nile Virus Protease Inhibitors With Submicromolar Activity in Reporter Gene DENV-2 Protease and Viral Replication Assays.

  2020cites this paper
• Broad‐Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View

  2020cites this paper
• Molecular docking and QSAR theoretical model for prediction of phthalazinone derivatives as new class of potent dengue virus inhibitors

  2020cites this paper
• Anti-Dengue potential, Molecular Docking Study of Some Chemical constituents in the leaves of Isatis tinctoria

  2020cites this paper
• Total synthetic approaches for lucidone: a promising natural lead candidate against dengue infection

  2019cites this paper
• Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.

  2019cites this paper
• Inhibition of Dengue Virus Protease by Eugeniin, Isobiflorin, and Biflorin Isolated from the Flower Buds of Syzygium aromaticum (Cloves)

  2019cites this paper
• The Application of Fragment-based Approaches to the Discovery of Drugs for Neglected Tropical Diseases

  2019cites this paper
• Non-Structural Proteases as a Target of Dengue Virus

  2019cites this paper
• Cysteine Disul fi de Traps Reveal Distinct Conformational Ensembles in Dengue Virus NS 2 BNS 3 Protease

  2019cites this paper
• Structure of dengue virus protease with an allosteric Inhibitor that blocks replication

  2019cites this paper
• Design, Synthesis, and Biological Evaluation of Substituted 4,6-Dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione Analogues as Potent NS4B Inhibitors for the Treatment of Dengue Virus Infection.

  2019cites this paper
• Peptide-β-lactam inhibitors of dengue and West Nile virus NS2B-NS3 protease display two distinct binding modes.

  2019cites this paper
• Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses.

  2019cites this paper
• Biocompatible Macrocyclization between Cysteine and 2-Cyanopyridine Generates Stable Peptide Inhibitors.

  2019cites this paper
• Inhibits Zika Virus NS 2 BNS 3 Protease

  2019cites this paper
• Quantum Mechanics/Molecular Mechanics (QM/MM) Calculations Support a Concerted Reaction Mechanism for the Zika Virus NS2B/NS3 Serine Protease with Its Substrate.

  2019cites this paper
• Proteases from dengue, West Nile and Zika viruses as drug targets

  2019cites this paper
• De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease.

  2019cites this paper
• Synthesis and structure-activity relationships of small-molecular di-basic esters, amides and carbamates as flaviviral protease inhibitors.

  2019cites this paper